Vascular Biogenics Ltd (NASDAQ:VBLT)

Delayed Data
As of Aug 03
 -0.05 / -3.82%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Vascular Biogenics Ltd have a median target of 3.38, with a high estimate of 5.00 and a low estimate of 2.50. The median estimate represents a +164.71% increase from the last price of 1.27.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Vascular Biogenics Ltd. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.33%
Growthannually -0.46%


Growthquarterly -53.55%
Growthannually 42.62%
Key to the earnings and sales forecast charts.